Loading clinical trials...
Loading clinical trials...
5 year, open-label study to evaluate safety of SCULPTRA on the signs of lipoatrophy of the face in at least 100 evaluable subjects with human immunodeficiency virus.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bausch Health Americas, Inc.
NCT05776836 · Facial Lipoatrophy (FLA)
NCT03050749 · Facial Lipoatrophy, Morphological Asymmetry of the Face, and more
NCT03050723 · Facial Lipoatrophy, Morphological Asymmetry of the Face, and more
Sanofi-Aventis Administrative Office
Bridgewater, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions